MingMed Funding: $243M Raised, IPO (2024)

MingMed funding overview

MingMed is based in Guangzhou, China. MingMed has raised $243M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in December 2024. The round record for MingMed runs through 2024; nothing later has been disclosed. Investors on record include Gaorong Ventures, Lightspeed China Partners, Flower City Venture Capital Management, JCP Capital, Zhuhai Huajin Capital, Henqin Financial Investment Group. 6 distinct backers are named across the disclosed rounds.

MingMed at a glance

Total raised: $243M
Latest round: IPO
Latest round date: December 2024
Headquarters: Guangzhou, China
Notable investors: Gaorong Ventures, Lightspeed China Partners, Flower City Venture Capital Management, JCP Capital, Zhuhai Huajin Capital, Henqin Financial Investment Group

Frequently asked about MingMed funding

How much has MingMed raised?: MingMed has raised $243M in total disclosed funding across the rounds on record.
Who has invested in MingMed?: Gaorong Ventures, Lightspeed China Partners, Flower City Venture Capital Management, JCP Capital, Zhuhai Huajin Capital, Henqin Financial Investment Group are named among the investors backing MingMed.
What was the latest MingMed funding round?: The most recent disclosed round is an IPO, announced in December 2024.
Where is MingMed based?: MingMed is based in Guangzhou, China.
When did MingMed last raise?: The last disclosed MingMed round closed in December 2024 at IPO.

Every MingMed figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Guangzhou at a similar stage.

MingMed Funding: $243M Raised, IPO (2024)

MingMed funding overview

MingMed at a glance

Frequently asked about MingMed funding

Companies related to MingMed (31)

Browse related funding lists (5)